120 related articles for article (PubMed ID: 3825864)
1. The value of mixed venous oxygen saturation as a therapeutic indicator in the treatment of advanced congestive heart failure.
Hassan E; Roffman DS; Applefeld MM
Am Heart J; 1987 Mar; 113(3):743-9. PubMed ID: 3825864
[TBL] [Abstract][Full Text] [Related]
2. Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
Nuñez S; Maisel A
Am Heart J; 1998 Mar; 135(3):383-8. PubMed ID: 9580093
[TBL] [Abstract][Full Text] [Related]
3. Cardiac index vs oxygen-derived parameters for rational use of dobutamine in patients with congestive heart failure.
Teboul JL; Graini L; Boujdaria R; Berton C; Richard C
Chest; 1993 Jan; 103(1):81-5. PubMed ID: 8417942
[TBL] [Abstract][Full Text] [Related]
4. Continuous monitoring of mixed venous oxygen saturation as an indicator of pharmacologic intervention.
Hassan E; Green JA; Nara AR; Jarvis RC; Kasmer RJ; Pospisil R
Chest; 1989 Feb; 95(2):406-9. PubMed ID: 2563343
[TBL] [Abstract][Full Text] [Related]
5. Relation between mixed venous oxygen saturation and cardiac index. Nonlinearity and normalization for oxygen uptake and hemoglobin.
Jain A; Shroff SG; Janicki JS; Reddy HK; Weber KT
Chest; 1991 Jun; 99(6):1403-9. PubMed ID: 1828020
[TBL] [Abstract][Full Text] [Related]
6. Relationship between mixed venous oxygen saturation and cardiac index in patients with chronic congestive heart failure.
Richard C; Thuillez C; Pezzano M; Bottineau G; Giudicelli JF; Auzepy P
Chest; 1989 Jun; 95(6):1289-94. PubMed ID: 2721268
[TBL] [Abstract][Full Text] [Related]
7. The SvO2 study: general design and results of the feasibility phase of a multicenter, randomized trial of three different hemodynamic approaches and two monitoring techniques in the treatment of critically ill patients. The SvO2 Collaborative Group.
Control Clin Trials; 1995 Feb; 16(1):74-87. PubMed ID: 7743791
[TBL] [Abstract][Full Text] [Related]
8. Mixed venous oxygen saturation as a promising parameter for physiologic control of total artificial heart.
Nakamura M; Homma A; Tatsumi E; Uesho K; Taenaka Y; Masuzawa T; Nakamura T; Zhang B; Kakuta Y; Imada K; Nakatani T; Takano H
ASAIO J; 2000; 46(6):761-6. PubMed ID: 11110277
[TBL] [Abstract][Full Text] [Related]
9. Effect of vasoactive treatment on the relationship between mixed venous and regional oxygen saturation.
Ruokonen E; Takala J; Uusaro A
Crit Care Med; 1991 Nov; 19(11):1365-9. PubMed ID: 1935155
[TBL] [Abstract][Full Text] [Related]
10. [The role of mixed venous oxygen saturation in perioperative monitoring and therapy. A critical stock taking].
Wiesemes R; Peters J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Aug; 28(5):269-78. PubMed ID: 8373972
[TBL] [Abstract][Full Text] [Related]
11. Changes in the mixed venous blood oxygen saturation during the acute phase of myocardial infarction and administration of dobutamine.
Koeda T; Amano K; Ichikawa T; Suzuki T; Ishikawa M; Sato M; Miura S; Suzuki T; Kato M
Tohoku J Exp Med; 1990 Jan; 160(1):55-65. PubMed ID: 2330581
[TBL] [Abstract][Full Text] [Related]
12. Can measurement of mixed venous oxygen saturation replace measurement of cardiac output in patients with advanced heart failure?
Gawlinski A
Am J Crit Care; 1998 Sep; 7(5):374-80; quiz 381-2. PubMed ID: 9740888
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of intraoperative continuous mixed venous oxygen saturation monitoring.
Naruns EB
AANA J; 1989 Feb; 57(1):45-52. PubMed ID: 2929243
[TBL] [Abstract][Full Text] [Related]
14. Physiologic rationale of Sv-O2 monitoring.
Mims BC
Crit Care Nurs Clin North Am; 1989 Sep; 1(3):619-28. PubMed ID: 2684246
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with continuous monitoring of mixed venous oxygen saturation in respiratory failure.
Fahey PJ; Harris K; Vanderwarf C
Chest; 1984 Nov; 86(5):748-52. PubMed ID: 6488914
[TBL] [Abstract][Full Text] [Related]
16. Value of the venous-arterial PCO2 gradient to reflect the oxygen supply to demand in humans: effects of dobutamine.
Teboul JL; Mercat A; Lenique F; Berton C; Richard C
Crit Care Med; 1998 Jun; 26(6):1007-10. PubMed ID: 9635647
[TBL] [Abstract][Full Text] [Related]
17. Cardiac output changes and continuous mixed venous oxygen saturation measurement in the critically ill.
Vaughn S; Puri VK
Crit Care Med; 1988 May; 16(5):495-8. PubMed ID: 3359787
[TBL] [Abstract][Full Text] [Related]
18. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Morelli A; Ertmer C; Lange M; Dünser M; Rehberg S; Van Aken H; Pietropaoli P; Westphal M
Br J Anaesth; 2008 Apr; 100(4):494-503. PubMed ID: 18308741
[TBL] [Abstract][Full Text] [Related]
19. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
[TBL] [Abstract][Full Text] [Related]
20. Central mixed and splanchnic venous oxygen saturation monitoring.
Dahn MS; Lange MP; Jacobs LA
Intensive Care Med; 1988; 14(4):373-8. PubMed ID: 3403769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
